Katie Arnold
Katie has three decades of experience in healthcare and has worked with a variety of medical companies including device, diagnostic, software, wearables, and tech-enabled solutions. Katie founded and leads SPRIG Consulting, a boutique firm that provides strategic marketing, commercialization, and business development services to companies ranging from venture-backed start-ups to Fortune 500 companies. Since its inception in 2008, SPRIG has partnered with over 350 medical companies with over 50 clients achieving exits in value of $50B. At SPRIG, Katie works closely with clients on the entire spectrum of commercialization needs: from early-stage market development strategies to downstream launch execution and commercialization efforts. Additionally, Katie co-founded and serves as Operating Partner for SPRIG Equity, a MedTech-focused venture and growth equity fund with over $50M in assets under management.
Prior to her work at SPRIG, Katie’s career included sales and marketing roles with Guidant Corporation (Acquired by ABT and BSX) and Kensey Nash Corporation (Acquired by Volcano Therapeutics).
At Kellogg, Katie has been a professor in the HCAK department for over 12 years, where she teaches Medtech Entrepreneurship, a course focused on medical product commercialization and financing. Additionally, each Spring Katie co-leads Kellogg’s Healthcare Entrepreneurship Forum and Business Plan Competition.
Katie holds an MBA from Northwestern University’s Kellogg Graduate School and a BA from the University of Vermont.
-
-
-
MBA, 2002, Marketing, Health Industry Management, and Biotechnology, Kellogg School of Management, Northwestern University
BA, 1994, Environmental Studies, University of Vermont -
Founder and Principal Consultant, Sprig Consulting, LLC, 2008-present
Director of Market Development, Kensey Nash Corporation, 2005-2008
Senior Global Product Manager, Vascular Intervention, Guidant Corporation, 2001-2005
Healthcare Risk Management Consultant, CNA Insurance Companies, 1996-2000
Associate Risk Management Consultant, MMI Insurance Company, 1994-1996
Medtech Entrepreneurship (HCAK-611-0)
This course offers students an experiential learning opportunity to work directly in the commercialization and fundraising process for innovative, pre-commercial medical technologies, to include devices, diagnostics, services and software solutions. The insights from this hands-on course will be most beneficial to students with an interest in entrepreneurship, start-ups, product design, early stage financing and product marketing. Students will be placed on three-to-four member teams based on their skills, experience and project interests. Each team will function as members of the executive team working with select Northwestern tech transfer companies curated by Northwestern's INVO (Innovation and New Ventures Office). Each company will present their technology on the first day of class, after which students will rank their top choices and will be matched by the faculty to meet top preferences. Once matched, students will work with their respective companies to build a complete investor deck that will be delivered to a panel of industry and finance experts at the end of the quarter. Each class includes a faculty lecture and guest lecture in an effort to bring real world experiences and perspectives to each topic. Since its inception, this course has produced companies that competed in and won prestigious business plan competitions. It has also graduated several technologies/companies that are now FDA cleared and commercially available.
Note: This course may not be dropped after the first week of the quarter.
